Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 11;58(2):397-411.e6.
doi: 10.1016/j.immuni.2025.01.006. Epub 2025 Jan 31.

Recirculating regulatory T cells mediate thymic regeneration through amphiregulin following damage

Affiliations

Recirculating regulatory T cells mediate thymic regeneration through amphiregulin following damage

Andri L Lemarquis et al. Immunity. .

Abstract

Thymic injury associated with disease or cancer treatment reduces T cell production and makes patients more vulnerable to infections and cancers. Here, we examined the role of regulatory T (Treg) cells on thymic regeneration. Treg cell frequencies increased in the thymus in various acute injury models. Depletion of Treg cells impaired thymic regeneration, impacting both the thymocyte compartment and the stromal cell compartment; adoptive transfer of Treg cells enhanced regeneration. Expansion of circulating Treg cells, as opposed to that of tissue resident or recent thymic emigrants, explained this increase, as seen using parabiotic and adoptive transfer models. Single-cell analyses of recirculating Treg cells revealed expression of various regenerative factors, including the cytokine amphiregulin. Deletion of amphiregulin in these Treg cells impaired regeneration in the injured thymus. We identified an analogous population of CD39+ICOS+ Treg cells in the human thymus. Our findings point to potential therapeutic avenues to address aging- and treatment-induced immunosuppression.

Keywords: Treg cells; Tregs; aging; amphiregulin; immune reconstitution; injury; parabiosis; recirculating Tregs; thymic regeneration; thymus.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests Dr. M.R.M.v.d.B has received research support and stock options from Seres Therapeutics and stock options from Notch Therapeutics and Pluto Therapeutics; has received royalties from Wolters Kluwer; has consulted, received honoraria from, or participated in advisory boards for Seres Therapeutics, Rheos Medicines, Ceramedix, Pluto Therapeutics, Thymofox, Garuda, Novartis (spouse), Synthekine (spouse), Beigene (spouse), and Kite (spouse); has IP licensing with Seres Therapeutics and Juno Therapeutics; and holds a fiduciary role on the Foundation Board of DKMS (a nonprofit organization).

References

    1. Palmer S, Albergante L, Blackburn CC, and Newman TJ (2018). Thymic involution and rising disease incidence with age. Proc Natl Acad Sci U S A 115, 1883–1888. 10.1073/pnas.1714478115. - DOI - PMC - PubMed
    1. Dekker L, de Koning C, Lindemans C, and Nierkens S (2020). Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation. Cancers (Basel) 12, 1974. 10.3390/cancers12071974. - DOI - PMC - PubMed
    1. Yoshida K, Cologne JB, Cordova K, Misumi M, Yamaoka M, Kyoizumi S, Hayashi T, Robins H, and Kusunoki Y (2017). Aging-related changes in human T-cell repertoire over 20years delineated by deep sequencing of peripheral T-cell receptors. Exp Gerontol 96, 29–37. 10.1016/j.exger.2017.05.015. - DOI - PubMed
    1. Kooshesh KA, Foy BH, Sykes DB, Gustafsson K, and Scadden DT (2023). Health Consequences of Thymus Removal in Adults. New England Journal of Medicine 389, 406–417. 10.1056/NEJMoa2302892. - DOI - PMC - PubMed
    1. Velardi E, Tsai JJ, and van den Brink MRM (2021). T cell regeneration after immunological injury. Nat Rev Immunol 21, 277–291. 10.1038/s41577-020-00457-z. - DOI - PMC - PubMed